Advertise on podcast: Withum Sounding Board

Join Withum's Application Modernization and Project Management experts as they discuss a budget line item nobody enjoys defending: outdated COBOL systems. So, what does it really take to modernize a COBOL environment? Listen in to explore the financial, operational and governance factors organizations should understand before launching a modernization initiative.

For the final installment of Withum's PMO series, our group of experts will cover what is perhaps the most consequential topic of all in project management — the people. Through real examples and experience, the group will discuss AI's real impact on project management talent, role archetypes, hiring criteria, development programs and more.

Host Cutty Thomas sits down with Bill Hagaman, board member across multiple life sciences companies, Global Chairman at HLB International and CEO emeritus at Withum. Together, they explore the evolving life sciences landscape, what investors and boards really look for in growth-stage companies, and how founders can craft pitches that stand out. Bill shares hard-won lessons from years of boardroom leadership, plus his outlook on the opportunities and challenges set to shape the industry's future.

New York's cannabis market is already at $2.5B in sales and heading toward $6.1B by 2033, but the biggest opportunities for growers may be sitting in the state's tax code. On this episode of What the Hemp, Withum's Ray Owens and Jonathan Tretter unpack the New York State credits and incentives cannabis producers should line up before they ever pick a site: the Brownfield Cleanup Program, Excelsior Jobs incentives, the 20% refundable Investment Tax Credit available to qualified farms, agricultural real estate exemptions, and the Workforce Retention Credit. They also flag the mistakes that trip up operators. If you're building, growing, or investing in New York cannabis, this is the planning conversation to have before you sign a lease.

In this episode of The C-Suite Spotlight, Cutty Thomas hosts Judith Wilks, Founder and Principal Consultant of Steadfast Ventures, to discuss what buyers really look for in today’s market. They explore how strong systems, operational stability, and documented processes drive enterprise value and reduce risk. Judith shares insights on transforming tribal knowledge into scalable assets and how leaders can build organizations that grow beyond individual contributors.

Greg Erman, serial entrepreneur, investor, and life sciences mentor, joins host Cutty Thomas to share a practical playbook for funding life sciences ventures, covering IP, revenue, and margin inflection points, investor expectations, and how founders can navigate dilution, scaling, and uncertainty to survive the “valley of death.”

This episode explores how PMOs can move beyond the waterfall vs. agile debate by adopting hybrid methodologies tailored to each project. Through real examples and practical steps, subject matter experts from Withum's Business and Management Consulting Services Team show how to balance structure and flexibility to navigate change management effectively.

CPA and Tax Supervisor Lindsey Valentine sits down with Withum Senior Tax Manager Raymond Owens to break down the most consequential tax legislation since the TCJA. From a major SALT cap increase to permanent bonus depreciation, restored R&D expensing, and a sweeping crackdown on hemp products, the One Big Beautiful Bill Act touches nearly every corner of the tax code. Whether you're a cannabis operator, manufacturer, or individual taxpayer, this episode gives you a practical roadmap for what's changing and how to position yourself for success.

Growth doesn’t break finance systems; it reveals where they were already failing. Hosted by Cutty Thomas, this conversation features Alexis Becker, Partner at Withum, sharing real world insights on cash flow visibility, delayed closes, disconnected systems and how CFOs can modernize financial processes to support scalable growth, better decision making and stronger leadership confidence.

In this episode of What the Hemp?, Kyle Wisniewski is joined by Raymond Owens and Ian Taylor to discuss how cannabis rescheduling could impact partnerships, pass-through entities, and tax planning strategies. With 280E potentially going away, many operators are wondering:  Should I stay a partnership? Should I convert to a C-Corp or an S-Corp? How will QBI and PTET rules change? What are the risks of restructuring too early? Our team of expert cannabis accountants breaks it all down.

In this episode of What the Hemp?, Steven Monacelli is joined by Dan Mayo and Brian Silva to unpack one of the most misunderstood topics in cannabis taxation: can cannabis businesses take a non-280E position? With rescheduling back in the headlines following President Trump’s executive order, many operators are asking whether they can stop applying 280E, or even amend prior returns. Rescheduling may be coming BUT 280E is still the law today. Taking aggressive positions without proper support can expose businesses to significant risk.

With cannabis rescheduling on the horizon, many operators are asking the same question: Should I change my entity structure now?  In this episode of What the Hemp, host Steven Monacelli is joined by Ray Owens, Senior Tax Manager at Withum, to break down what rescheduling could mean for cannabis businesses and why restructuring isn’t always as simple as it sounds.

In this episode of What the Hemp, host Steven Monacelli is joined by Ray Owens, Senior Tax Manager at Withum, to break down one of the most important topics facing cannabis operators today: How federal rescheduling could impact your entity structure, tax burden, and exit strategy.

In this episode of The C‑Suite Podcast, host Cutty Thomas, interviews Dom Hebrault, Associate Director of Process Technologies, who brings extensive experience in digital and laboratory technologies across biotech and pharma.  Dom shares his unique career journey spanning CDMOs, large pharmaceutical organizations, robotics and automation, and even space‑based drug research. He breaks down the science behind today’s most exciting breakthroughs, from AI-powered drug discovery and CRISPR advancements to mRNA platforms and cancer immunotherapy and explains how these innovations shape modern drug development and manufacturing.

In this episode of The Withum Sounding Board, Derek White is joined by Darcey Long for a deep dive into the most common mistakes companies make when claiming the R&D tax credit, and how to avoid them. Building on their previous discussion, Derek and Darcey unpack the often-overlooked areas that can make or break an R&D credit claim. Tune in to learn how to protect your credit, strengthen documentation, and unlock the full value of your R&D investments.